Product Information
QUETIAPINE ER 150 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1822 per EA under NDC 33342013409. Its NADAC has been published 424 times since May 16, 2018.
Strength
150 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342013409
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204253On Market Since
11/1/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 150 MG TABLET has been published 424 times since May 16, 2018, and over the history we have for it it has declined 74.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1822 per EA |
|---|---|
| All-time high | $0.7134 (May 16, 2018) |
| All-time low | $0.1497 (Nov 20, 2024) |
| 52-week high | $0.2205 |
| 52-week low | $0.1813 |
| Median price | $0.2578 |
| Average price | $0.3065 |
| Largest weekly change | +43.5% (Apr 21, 2021) |
| Weeks tracked | 424 |
| Tracking since | May 16, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the QUETIAPINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 150 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1822 per EA (NDC 33342013409), effective Jun 24, 2026.
How has the price of QUETIAPINE ER 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 150 MG TABLET has declined 74.5%. It has been tracked across 424 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 150 MG TABLET?
Since May 16, 2018, the NADAC for QUETIAPINE ER 150 MG TABLET has ranged from a low of $0.1497 (Nov 20, 2024) to a high of $0.7134 (May 16, 2018), with a median of $0.2578 per EA.
Are there cheaper alternatives to QUETIAPINE ER 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QUETIAPINE ER 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures QUETIAPINE ER 150 MG TABLET?
QUETIAPINE ER 150 MG TABLET (NDC 33342013409) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification